newsfilter
← Latest News
GlobeNewswire·

Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025

SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC:RGBP) and (OTC:RGBPP) today announced the Company will be presenting an update on its application for Orphan Drug status to the U.S. Food and